A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Hernán, Miguel A., Takkouche, Bahi, Caamaño‐Isorna, Francisco, Gestal‐Otero, Juan J.·2002·Annals of Neurology

DOI 10.1002/ana.10277

Cited by (817)

Items 401–500 of 817

A review of diagnostic imaging approaches to assessing Parkinson's disease
Ethan Samson, Michael D. Noseworthy · 2022 · Brain Disorders
Prevalence of Parkinson's disease in Northern Jordan
Ali H. Alrefai, Majed Habahbih, Mohammad M. Alkhawajah, Mohammad Darwish, Waleed Batayha, Yousef Saleh Khader, Khalid El‐Salem · 2009 · Clinical Neurology and Neurosurgery
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
Haruka Takeshige‐Amano, Shinji Saiki, Motoki Fujimaki, Shin‐Ichi Ueno, Yuanzhe Li, Taku Hatano, Kei‐ichi Ishikawa, Yutaka Oji, Akio Mori, Ayami Okuzumi et al. · 2020 · Movement Disorders
Dietary nicotine intake and risk of Parkinson disease: a prospective study
Chaoran Ma, Samantha A. Molsberry, Yanping Li, Michael A. Schwarzschild, Alberto Ascherio, Xiang Gao · 2020 · American Journal of Clinical Nutrition
Quitting smoking: An early non-motor feature of Parkinson's disease?
Marcello Moccia, Roberto Erro, Marina Picillo, Edoardo Vassallo, Carmine Vitale, Katia Longo, Marianna Amboni, Gabriella Santangelo, Raffaele Palladino, Antonio Nardone et al. · 2014 · Parkinsonism & Related Disorders
Prediction of Parkinson’s disease subsequent to severe depression: a ten-year follow-up study
Uwe Walter, Robert Heilmann, Lara Kaulitz, Tino Just, Bernd Joachim Krause, R. Benecke, Jacqueline Höppner · 2014 · Journal of Neural Transmission
Mortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder
Junying Zhou, Jihui Zhang, Siu Ping Lam, Vincent Mok, Anne Y. Y. Chan, Shirley Xin Li, Yaping Liu, Xiangdong Tang, Wing‐Ho Yung, Yun Kwok Wing · 2016 · SLEEP
Evidence for association between hepatitis C virus and Parkinson’s disease
Abdelrahman Ibrahim Abushouk, Mostafa Wanees Ahmed El Husseny, Mayar Magdy, Ammar Ismail, Attia Attia, Hussien Ahmed, Ravikishore Pallanti, Ahmed Negida · 2017 · Neurological Sciences
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson’s Disease Penetrance
Alessandra Zanon, Peter Paul Pramstaller, Andrew A. Hicks, Irene Pichler · 2018 · Parkinson s Disease
Etiology and Pathogenesis of Parkinson’s Disease
Taku Hatano, Nobutaka Hattori · 2011 · InTech eBooks
Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(α)pyrene
Maria Konstandi, Panagiotis Harkitis, Kyriaki Thermos, Sven Ove Ögren, Elizabeth O. Johnson, Panagiotis Tzimas, Μάριος Μαρσέλος · 2007 · NeuroToxicology
Solvent exposed occupations and risk of Parkinson disease in Finland
Susan Searles Nielsen, Mark N. Warden, Markku Sallmén, Markku Alarik Sainio, Sanni Uuksulainen, Harvey Checkoway, Christer Hublin, Brad Alan Racette · 2021 · Clinical Parkinsonism & Related Disorders
Salivary caffeine in Parkinson’s disease
Giorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, Alessia Ciogli, Andrea Fabbrini, Matteo Costanzo, Simone Manetto, Antonella Conte, Claudio Villani, Giovanni Fabbrini et al. · 2021 · Scientific Reports
Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson’s disease based on network pharmacology approach
Fangjun Li, Taku Hatano, Nobutaka Hattori · 2021 · Journal of Functional Foods
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study
V. Gallo, Carol Brayne, Lars Forsgren, Roger A. Barker, Jesper Petersson, Oskar Hansson, Daniel Lindqvist, Claudio Ruffmann, Lianna Ishihara, Robert Luben et al. · 2015 · Neurodegenerative Diseases
The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway
Arnold J. Levine, Chris R. Harris, Anna M. Puzio‐Kuter · 2012 · Oncotarget
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease
Jing Hu, Pedro A. Ferchmin, Ann M. Hemmerle, Kim B. Seroogy, Vesna A. Eterović, Jiukuan Hao · 2017 · Frontiers in Neuroscience
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson’s disease
A. Gigante, A. Asabella, G. Iliceto, T. Martino, C. Ferrari, G. Defazio, G. Rubini · 2018 · Neurological Sciences
Alzheimer’s and Parkinson’s Diseases and the Risk of Cancer: A Cohort Study
Anne Gulbech Ording, Katalin Veres, Erzsébet Horváth–Puhó, M. Maria Glymour, Mikael Rahbek Rørth, Victor W. Henderson, Henrik Toft Sørensen · 2019 · Journal of Alzheimer s Disease
Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use
Iris Y. Kim, Éilis J. O’Reilly, Katherine C. Hughes, Xiang Gao, Michael A. Schwarzschild, Alberto Ascherio · 2017 · Journal of Parkinson s Disease
Parkinson's Disease: Genetics and Pathogenesis
Claudia M. Testa · 2007 · Wiley eBooks
Parkinson’s disease and risk of prostate cancer: A Danish population-based case-control study, 1995–2010
Christina Gade Jespersen, Mette Nørgaard, Michael Borre · 2016 · Cancer Epidemiology
Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease
Sasivimol Virameteekul, Andrew John Lees, Roongroj Bhidayasiri · 2024 · Movement Disorders
Coffee consumption and risk of levodopa‐induced dyskinesia in Parkinson's disease: The FRAGAMP study
Alessandra Susie Quesado Nicoletti, Mario Zappia, on behalf of the FRAGAMP Study Group · 2015 · Movement Disorders
Phenotypic Characteristics in GBA-Associated Parkinson’s Disease: A Study in a Greek Population
Athina‐Maria Simitsi, Christos Koros, Marina Moraitou, Nikolaos Papagiannakis, Roubina Ch. Antonelou, Maria Bozi, Efthalia Angelopoulou, María Stamelou, Helen Michelakakis, Leonidas Stefanis · 2018 · Journal of Parkinson s Disease
Association Between Parkinsonism and Participation in Agriculture in Korea
Jinwhan Cho, Beom S. Jeon, Dushin Jeong, Yoonjae Choi, Jun‐Young Lee, Hae-Sung Lee, Sae‐Yong Hong · 2008 · Journal of Clinical Neurology
Neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism
Yujeong Lee, Min‐Sun Kim, Jaewon Lee · 2017 · Archives of Pharmacal Research
Comparison of Environmental and Genetic Factors for Parkinson’s Disease between Chinese and Caucasians
Daniel Kam Yin Chan, Dennis John Cordato, Triet Bui, George D. Mellick, Jean Woo · 2004 · Neuroepidemiology
Population fraction of Parkinson’s disease attributable to preventable risk factors
Haydeh Payami, Gwendolyn Cohen, Charles Murchison, Timothy Robert Sampson, David G. Standaert, Zachary D. Wallen · 2023 · npj Parkinson s Disease
Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women
Marie Löf, Sven Sandin, Li Yin, Hans‐Olov Adami, Elisabete Weiderpass · 2015 · European Journal of Epidemiology
History of smoking and olfaction in Parkinson's disease
Elisabeth B. Lucassen, Nicholas W. Sterling, Eun‐Young Lee, Honglei Chen, Mechelle M. Lewis, Lan Kong, Xuemei Huang · 2014 · Movement Disorders
Occupational Exposure to Whole-Body Vibration and Parkinson's Disease: Results From a Population-based Case-Control Study
M. A. Harris, Stephen A. Marion, John Joseph Spinelli, Joseph K.C. Tsui, Kay Teschke · 2012 · American Journal of Epidemiology
Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases
Keerti Mishra, Rafquat Rana, Shourya Tripathi, Shumaila Siddiqui, Pavan Kumar Yadav, Prem Narayan Yadav, Manish K. Chourasia · 2023 · Neurochemical Research
Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease
Gael Le Douaron, Fanny Schmidt, Majid Amar, Hanane Kadar, Lucila Debortoli, Alexandra Latini, Blandine Séon‐Méniel, Laurent Ferrié, Patrick Pierre Michel, David Touboul et al. · 2014 · European Journal of Medicinal Chemistry
Effect of chlorogenic acids on fatigue and sleep in healthy males: A randomized, double‐blind, placebo‐controlled, crossover study
Ryuji Ochiai, Kazuichi Tomonobu, Ippei Ikushima · 2018 · Food Science & Nutrition
Overall and cause-specific mortality in a cohort of farmers and their spouses
Srishti Shrestha, Christine Gibson Parks, Alexander P. Keil, David M. Umbach, Catherine Chase Lerro, Charles F. Lynch, Honglei Chen, Aaron E. Blair, Stella Koutros, Jonathan N Hofmann et al. · 2019 · Occupational and Environmental Medicine
Alcohol Intake and Parkinson's Disease Risk in the Million Women Study
Iris Y. Kim, TienYu Owen Yang, Alicia K. Heath, Rachel F Simpson, GILLIAN K. REEVES, Jane Green, Sarah Floud, Anna Brown, David J. Hunter, Valerie Beral et al. · 2019 · Movement Disorders
Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: phenolics and caffeine metabolites
M. A. Rathod, Deepa K. Patel, A. Das, Smitha R. Tipparaju, S. S. Shinde, Robert F. Anderson · 2013 · Free Radical Research
Parkinson's disease mortality among male anesthesiologists and internists
Chava Peretz, Bruce H. Alexander, Sonia I. Nagahama, Karen B. Domino, Harvey Checkoway · 2005 · Movement Disorders
Efeitos da estimulação cerebral profunda bilateral do núcleo subtalâmico sobre a sensibilidade e a dor em indivíduos com doença de Parkinson idiopática
Rubens Gisbert Cury · 2015
Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude
Yu Cao, Gongfeng Li, Jinsheng Xue, Guijuan Zhang, Sensen Gao, Yu‐Ling Huang, Aiqin Zhu · 2021 · Neuropsychiatric Disease and Treatment
Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea
So Young Kim, Hyo Geun Choi, Yoo Hwan Kim, Mi Jung Kwon, Joo‐Hee Kim, Heui Seung Lee, Ji Hee Kim · 2023 · npj Parkinson s Disease
Significance of nicotine and nicotinic acetylcholine receptors in Parkinson’s disease
Lin Xia, Qian Li, Min Pu, Hao Dong, Qinghua Zhang · 2025 · Frontiers in Aging Neuroscience
Norharman and harman in instant coffee and coffee substitutes
Rita Carneiro Alves, Eulália Mendes, M. Beatriz P.P. Oliveira, Susana I.P. Casal · 2009 · Food Chemistry
Factors influencing the development of early- or late-onset Parkinson’s disease in a cohort of South African patients
Celia van der Merwe, William Lloyd Haylett, Justin Harvey, Debbie Lombard, Soraya Bardien, Jonathan Ambrose Carr · 2012 · South African Medical Journal
Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat
Siamak Reyhani‐Rad, Javad Mahmoudi · 2016 · Acta Cirúrgica Brasileira
Genetic variants in nicotinic receptors and smoking cessation in Parkinson's disease
Yu‐Hsuan Chuang, Kimberly C. Paul, Janet S. Sinsheimer, Jeff M. Bronstein, Yvette M. Bordelon, Beate R. Ritz · 2019 · Parkinsonism & Related Disorders
Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease
Emilio Fernández‐Espejo, Fernando Rodrı́guez de Fonseca, Juan Suárez, EDUARDO S. TOLOSA, Dolores Vilas, Ibán Aldecoa, Juan Berenguer, Fátima Damas-Hermoso · 2021 · Antioxidants
6-OHDA-Induced Changes in Parkinson`s Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells
Tomasz Maciej Stępkowski, Iwona Wasyk, Agnieszka Grzelak, Marcin K. Kruszewski · 2015 · Cellular and Molecular Neurobiology
Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease
Eng‐King Tan, Z.Y. Lu, Stephanie Man Chung Fook-Chong, E. Tan, Hui Shen, E. Chua, Y. Yih, Yik‐Ying Teo, Yi Zhao · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Association between smoking and all-cause mortality in Parkinson’s disease
Seo Yeon Yoon, Yu Hyun Park, Sang Chul Lee, Jee Hyun Suh, Seung Nam Yang, Dae Ryong Kang, Yong Wook Kim · 2023 · npj Parkinson s Disease
Investigating the role of chlorogenic acids and coffee type in coffee-induced teeth discoloration
Soyeon Kim, Shin Hye Chung, Ryan Jin‐Young Kim, Young‐Seok Park · 2023 · Acta Odontologica Scandinavica
Beverages – a scoping review for Nordic Nutrition Recommendations 2023
Emily Sonestedt, Marko Lukic · 2024 · Food & Nutrition Research
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Cristiana Vilela, Bruna Araújo, Carla Soares-Guedes, Rita Caridade-Silva, Joana Martins‐Macedo, Catarina Teixeira, Eduardo D. Gomes, Cristina Prudêncio, Mónica Vieira, Fábio Gabriel Teixeira · 2024 · Cells
Smoking, coffee intake, and Parkinson’s disease: Potential protective mechanisms and components
Sa Weon Hong, Rachel Page, Penelope Truman · 2024 · NeuroToxicology
Role of genomics in translational research for Parkinson’s disease
Kazunari Sekiyama, Yoshiki Takamatsu, Masaaki Waragai, Makoto Hashimoto · 2014 · Biochemical and Biophysical Research Communications
Promise of Pharmacogenomics for Drug Discovery, Treatment and Prevention of Parkinson's Disease. A Perspective
Haydeh Payami, Stewart Alan Factor · 2013 · Neurotherapeutics
Harmine Acts as an Indirect Inhibitor of Intracellular Protein Aggregation
Swati Jain, Venkataharsha Panuganti, Sonali Jha, Ipsita Roy · 2020 · ACS Omega
Revisiting the Association Between Inflammatory Bowel Disease and Parkinson’s Disease
Matthew D. Coates, Djibril M. Ba, Guodong Liu, Shannon Dalessio, DOUGLAS L. LESLIE, Xuemei Huang · 2021 · Inflammatory Bowel Diseases
Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician
Lorenzo Falsetti, Giovanna Viticchi, Vincenzo Zaccone, Nicola Tarquinio, Lorenzo Nobili, Cinzia Nitti, Aldo Salvi, Gianluca Moroncini, Mauro Silvestrini · 2021 · Medical Principles and Practice
Chronic Neurodegenerative Illnesses and Epilepsy in Danish Adventists and Baptists: A Nationwide Cohort Study
Lau Caspar Thygesen, Louise Nørreslet Gimsing, Andrea Bautz, Niels Christian Hvidt, Christoffer Johansen · 2017 · Journal of Alzheimer s Disease
Activation of α7-nAChRs Promotes the Clearance of α-Synuclein and Protects Against Apoptotic Cell Death Induced by Exogenous α-Synuclein Fibrils
Jifeng Zhao, Yun Li, Yan Li, Shi Xu, Tingting Tao, Hua Ye, Ji Zhang, Yi Fan · 2021 · Frontiers in Cell and Developmental Biology
Study of the Effects of Nicotine and Caffeine for the Treatment of Parkinson’s Disease
Sima Biswas, Angshuman Bagchi · 2022 · Applied Biochemistry and Biotechnology
Global Epidemiology of Movement Disorders: Rare or Underdiagnosed?
Sarah A. O’Shea, Ludy C. Shih · 2023 · Seminars in Neurology
Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
Olakunle J. Onaolapo, Ademola O. Odeniyi, Adejoke Y. Onaolapo · 2021 · CNS & Neurological Disorders - Drug Targets
Association between β2-Adrenoreceptor Medications and Risk of Parkinson’s Disease: A Meta-Analysis
Chu-Ling Chen, Shuyi Wang, Ta-Cheng Chen, Chieh‐Sen Chuang · 2021 · Medicina
A model for self-treatment of four sub-types of symptomatic ‘depression’ using non-prescription agents: Neuroticism (anxiety and emotional instability); malaise (fatigue and painful symptoms); demotivation (anhedonia) and seasonal affective disorder ‘SAD’
Bruce G. Charlton · 2008 · Medical Hypotheses
Female gender but not cigarette smoking delays the onset of Parkinson's disease
Abelardo Martinez‐Rumayor, Oscar G. Arrieta, Julio Sotelo, Esperanza Garcı́a · 2009 · Clinical Neurology and Neurosurgery
Coffee Consumption and Whole-Blood Gene Expression in the Norwegian Women and Cancer Post-Genome Cohort
Runa Borgund Barnung, Therese Haugdahl Nøst, Stine Marie Ulven, Guri Skeie, Karina S. Olsen · 2018 · Nutrients
Exploring the relationship between caffeine intake and essential tremor
K.M. Prakash, S. Fook‐Choong, Y. Yuen, Eng‐King Tan · 2006 · Journal of the Neurological Sciences
The ever‐stimulating association of smoking and coffee and Parkinson's disease
Karen S. Marder, Giancarlo Logroscino · 2002 · Annals of Neurology
Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls
Jonas Bačelis, Michele Compagno, Sonia George, John Andrew Pospisilik, Patrik Brundin, Åsa Torinsson Naluai, Lena Brundin · 2021 · Journal of Parkinson s Disease
Smoking, genes encoding dopamine pathway and risk for Parkinson's disease
Zhuqin Gu, Xiuli Feng, Xiumin Dong, Piu Chan · 2010 · Neuroscience Letters
Recognition and management of Parkinson’s disease during the premotor (prodromal) phase
Daniel D. Truong, Erik Ch. Wolters · 2009 · Expert Review of Neurotherapeutics
DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient
Liyong Wang, Lizmarie G. Maldonado, Gary W. Beecham, Eden R. Martin, Marian Leslie Evatt, James Ritchie, Jonathan L. Haines, Cyrus P. Zabetian, Haydeh Payami, Margaret Ann Pericak‐Vance et al. · 2016 · Neurology Genetics
Passive smoking and Parkinson's disease in California Teachers
Nicole M. Gatto, Dennis Deapen, Yvette M. Bordelon, Sarah F. Marshall, Leslie Bernstein, Beate R. Ritz · 2017 · Parkinsonism & Related Disorders
Height as a potential indicator of early life events predicting Parkinson's disease: A case‐control study
Paolo Ragonese, Marco D’Amelio, Graziella Callari, Fabio Aiello, Letterio Morgante, Giovanni Savettieri · 2007 · Movement Disorders
The Structure of the Adenosine Receptors
J. Robert Lane, Veli‐Pekka Jaakola, Adriaan P. IJzerman · 2011 · Advances in pharmacology
Caffeine and Parkinson disease
David G. Muñoz, Shinsuke Fujioka · 2018 · Neurology
β2‐Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk
Bojing Liu, Per Svenningsson, Jonas Filip Ludvigsson, Cecilia Lundholm, Johan Wallin, Henrik Larsson, Arvid Sjölander, Dylan M. Williams, Nancy L. Pedersen, Karin Wirdefeldt · 2023 · Annals of Neurology
Coffee and Microbiota: A Narrative Review
Federico Rosa, Benedetta Marigliano, Sergio Mannucci, Marcello Candelli, Gabriele Savioli, Giuseppe Merra, Christian Zanza, Antonio Gasbarrini, Francesco Franceschi, Andrea Piccioni · 2024 · Current Issues in Molecular Biology
Neuropathology and neuroinflammation in Alzheimer’s disease via bidirectional lung–brain axis
Jie Lu, Chengjun Li, Jing Wang, Yang Wang · 2024 · Frontiers in Aging Neuroscience
Residential exposure to road and railway traffic noise and incidence of dementia: The UK Biobank cohort study
Enock Havyarimana, Xiangpu Gong, Calvin Jephcote, Sarah Johnson, Sana Suri, Wuxiang Xie, Charlotte Clark, Anna Hansell, Yutong Samuel Cai · 2025 · Environmental Research
La cafeína como un fármaco preventivo de la enfermedad de Parkinson: evidencias epidemiológicas y sustrato experimental
José Luis Góngora-Alfaro · 2010 · Revista de Neurología
General and abdominal adiposity and the risk of Parkinson's disease: A prospective cohort study
Lukas Riso, Rudolf Kaaks, Tilman E. Kuhn, Disorn Sookthai, Lars Forsgren, Miles Trupp, Antonia Trichopoulou, Carlo La Vecchia, Anna Karakatsani, Diana Gavrila et al. · 2019 · Parkinsonism & Related Disorders
Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease
Emilio Fernández‐Espejo, Fernando Rodrı́guez de Fonseca, Ana Gavito, Antonio Córdoba-Fernández, José Chacón, Ángel Martín de Pablos · 2022 · Antioxidants
β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
Tomás Herraiz · 2023 · Molecules
Recent Studies on Nutrition and Parkinson’s Disease Prevention: A Systematic Review
Ann Gaba · 2015 · Open Journal of Preventive Medicine
CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking
Anat Bar‐Shira, Mali Gana‐Weisz, Ziv Gan‐Or, Eytan Giladi, Nir Giladi, Avi Orr‐Urtreger · 2014 · Neurobiology of Aging
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population‐based cohort: the Cardiovascular Health Study
Thanh G.N. Ton, Mary Lou Biggs, DIANE M. COMER, Lesley H. Curtis, Shu‐Ching Hu, Evan L. Thacker, Susan Searles Nielsen, Joseph A. Delaney, Douglas P. Landsittel, William T. Longstreth Jr. et al. · 2013 · Pharmacoepidemiology and Drug Safety
Cigarette smoking, coffee intake and alcohol consumption preceding Parkinson's disease: a case–control study
Sandra Šipetić Grujičić, Hristina Vlajinac, Jadranka M. Maksimovic, Jelena Marinković, Eleonora D. Dzoljic, Isidora Ratkov, V.S. Kostić · 2011 · Acta Neuropsychiatrica
Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control Study
Maya R. Silver, Brad Alan Racette, Umber Dube, Irene M. Faust, Susan Searles Nielsen · 2020 · Journal of Parkinson s Disease
Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose
Emilio Fernández‐Espejo, Fernando Rodrı́guez de Fonseca, Juan Suárez, Ángel Martín de Pablos · 2021 · Brain Research
Effects of particulate matter and nicotine for the MPP+-induced SH-SY5Y cells: Implication for Parkinson’s disease
Yu Jin Jung, Hyunsu Choi, Eungseok Oh · 2021 · Neuroscience Letters
Coffee aroma constituents and odorant metabolites in human urine
Maria Wagenstaller, Andrea Buettner · 2013 · Metabolomics
Association of rs1801582 and rs1801334 PARK2 Polymorphisms with risk of Parkinson's disease: A case-control study in South India and Meta-Analysis
Ramakrishnan Veerabathiran, Thomas Alphonsa, Akram Husain RS, Shiek S. S. J. Ahmed, K. Subramaniyan, Suresh S. Kumar · 2016 · Meta Gene
A Case–Control Study of the Effects of Chimarrão (Ilex paraguariensis) and Coffee on Parkinson's Disease
Márcio Schneider Medeiros, Artur Francisco Schumacher Schuh, Vivian Altmann, Carlos Roberto de Mello Rieder · 2021 · Frontiers in Neurology
A Diet for Dopaminergic Neurons?
Giuseppe Di Giovanni · 2009 · Springer eBooks
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
Alexander V. Blagov, Andrey G. Goncharov, Olga Babich, Viktoria Larina, Alexander Nikolaevich Orekhov, Alexandra А. Melnichenko · 2022 · Pharmaceutics